Please login to the form below

Not currently logged in
Email:
Password:

Anti-CD47

This page shows the latest Anti-CD47 news and features for those working in and with pharma, biotech and healthcare.

AbbVie signs immunotherapy pact with I-Mab worth $2bn

AbbVie signs immunotherapy pact with I-Mab worth $2bn

Focus of deal is anti-CD47 monoclonal antibody lemzoparlimab. AbbVie has bulked up its immunotherapy pipeline after signing a deal worth $2bn for rights to Shanghai-based I-Mab’s ... Some cancer cells express CD47 at very high levels and this seems to

Latest news

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....